Clear cell adenocarcinoma of the cervix in a child without in utero exposure to diethylstilbestrol: A case report and review of the literature

Pediatric and Developmental Pathology

Volumn 8, Issue 6, 2005, Pages 690-695

  Ahrens, William A ^a   Barrón Rodriguez, L Patricia ^a   McKee, Millisa ^a   Rivkees, Scott ^a   Reyes Múgica, Miguel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clear cell adenocarcinoma; Diethylstilbestrol; Uterine cervical tumors in children

Indexed keywords

DIETHYLSTILBESTROL;

ADENOCARCINOMA; CASE REPORT; CLEAR CELL ADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; EMBRYONAL RHABDOMYOSARCOMA; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; TUMOR DIAGNOSIS; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CHILD; DIAGNOSIS, DIFFERENTIAL; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RHABDOMYOSARCOMA, EMBRYONAL; UTERINE CERVICAL NEOPLASMS;

EID: 29244445493     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-005-0047-2     Document Type: Review

References (24)

1. Tavassoli FA, Deville P. WHO Classification Tumours of the Breast and Female Genital Organs, Volume 6. Lyon: IARC Press, 2003;297-301.
2. Blythe JG, Michael H, Hodel KA. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma. J Reprod Med 1983;28:137-145.
3. Waggoner SE, Anderson SM, Van Eyeck S, Fuller J, Luce MC, Herbst AL. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol 1994;84:404-408.
4. Greenwald P, Barlow J, Nasca PC, Burnett W. Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 1971;285:390-392.
5. Gilson MD, Dibona DD, Knab DR. Clear cell adenocarcinoma in young females. Obstet Gynecol 1973;41:494-500.
6. Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med 1971;316:514-516.
7. Boyd J, Takahashi H, Waggoner SE, Jones LA, Hajek RA, Wharton JT, Liu FS, Fujino T, Barrett JC, McLachlan JA. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer 1996;77:505-513.
8. Waggoner SE, Baunoch DA, Anderson SA, Leigh F, Zagaja VG. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53. Ann Surg Oncol 1998;5:544-547.
9. Waggoner SE, Anderson SM, Luce MC, Takahashi H, Boyd J. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol. 1996;60:339-344.
10. Resnik E, Christopherson WA, Stock R. Clear cell adenocarcinoma of the cervix and vagina in a woman with mixed gonadal dysgenesis. A case report. J Reprod Med 1989;34:981-984.
11. Hanselaar A, Van Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bernheim J. Clear cell adenocarcinoma of the vagina and cervix. An update of the Central Netherlands Registry showing twin age incidence peaks. Cancer 1997;79:2229-2236.
12. Yavuz H, Arslan A, Avsaz AF. Vaginal clear cell adenocarcinoma in an infant. Pediatr Hematol Oncol 1996;13:577-580.
13. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970;25:745-757.
14. Matias-Guiu X, Lerma E, Prat J. Clear cell tumors of the female genital tract. Semin Diagn Pathol 1997;14:233-239.
15. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-881.
16. Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology 1995;51:435-445.
17. Netzloff ML. Induction of urogenital neoplasia and abnormalities from prenatal exposure to diethylstilbestrol. Ann Clin Lab Sci 1979;9:263-267.
18. Monaghan JM, Sirisena L. Stilboestrol and vaginal clear-cell adenocarcinoma syndrome. Br Med J 1978;1:1588-1590.
19. Reich O, Tamussino K, Lahousen M, Pickel H, Haas J, Winter R. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 2000;76:331-335.
20. Robboy ST, Kaufman RH, Prat J, Welch WR, Gaffey T, Scully RE, Richart R, Fenoglio CM, Virata R, Tilley BC. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol 1979;53:309-317.
21. Nappi O, Mills SE, Swanson PE, Wick MR. Clear cell tumors of unknown nature and origin. A systematic approach to diagnosis. Semin Diagn Pathol 1997;14:164-174.
22. Accetta GS, Rivoire AW, Monego IH, Vettori DA, De Oliveira Freitas DM, Edelweiss MA, Capp E. Vaginal adenosis in a non-diethylstilbestrol-exposed 6-year-old patient. Gynecol Obstet Invest 2001;51:271-273.
23. Kurman RJ, Scully RE. The incidence and histogenesis of vaginal adenosis. An autopsy study. Hum Pathol 1974;5:265-276.
24. Doshi N, Fujikura T, Kanbour A. Vaginal adenosis and polycystic ovaries during infancy and childhood. Am J Obstet Gynecol 1977;129:374-878.